Kane Biotech Inc Cash Flow-to-Debt Ratio
Kane Biotech Inc cash flow-to-debt ratio. Kane Biotech Inc (KNE) has a Cash Flow-to-Debt Ratio of -0.20x as of December 2025, meaning its operating cash flow of CA$-680.61K could theoretically repay 0% of its total liabilities (CA$3.48 Million) in one year. Check Kane Biotech Inc earnings quality ratio to evaluate the quality of earnings relative to operating cash generation.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Kane Biotech Inc (2003–2025)
Cash flow-to-debt ratio of Kane Biotech Inc from 2003 to 2025. Historical debt coverage capacity for Kane Biotech Inc across 23 annual periods. Check total reinvestment intensity of Kane Biotech Inc to assess the company's total reinvestment commitment from operating cash flow.
Kane Biotech Inc Cash Flow-to-Debt Ratio by Year (2003–2025)
Kane Biotech Inc cash flow-to-debt ratio by year from 2003 to 2025. Year-by-year debt coverage analysis for Kane Biotech Inc. For the full cash flow conversion analysis, see how efficiently does Kane Biotech Inc generate cash.
| Year | CF-to-Debt Ratio | Operating CF (CAD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -0.94x | CA$-3.26 Million | CA$3.48 Million | ▲ +6.2% |
| 2024 | -1.00x | CA$-4.11 Million | CA$4.12 Million | ▼ -574.7% |
| 2023 | -0.15x | CA$-2.08 Million | CA$14.09 Million | ▲ +52.6% |
| 2022 | -0.31x | CA$-3.04 Million | CA$9.76 Million | ▼ -4.9% |
| 2021 | -0.30x | CA$-2.29 Million | CA$7.70 Million | ▲ +70.1% |
| 2020 | -0.99x | CA$-3.94 Million | CA$3.96 Million | ▼ -99.7% |
| 2019 | -0.50x | CA$-955.37K | CA$1.92 Million | ▲ +55.7% |
| 2018 | -1.12x | CA$-2.85 Million | CA$2.54 Million | ▲ +63.8% |
| 2017 | -3.10x | CA$-2.04 Million | CA$659.03K | ▼ -2.9% |
| 2016 | -3.02x | CA$-2.36 Million | CA$783.72K | ▼ -50.5% |
| 2015 | -2.00x | CA$-1.39 Million | CA$692.86K | ▼ -26.9% |
| 2014 | -1.58x | CA$-1.05 Million | CA$664.51K | ▲ +18.7% |
| 2013 | -1.94x | CA$-1.17 Million | CA$600.31K | ▲ +70.3% |
| 2012 | -6.54x | CA$-1.16 Million | CA$176.73K | ▲ +35.5% |
| 2011 | -10.14x | CA$-940.30K | CA$92.72K | ▼ -16.2% |
| 2010 | -8.73x | CA$-792.06K | CA$90.75K | ▲ +21.6% |
| 2009 | -11.14x | CA$-764.26K | CA$68.62K | ▲ +17.4% |
| 2008 | -13.49x | CA$-1.07 Million | CA$79.56K | ▼ -48.5% |
| 2007 | -9.09x | CA$-798.38K | CA$87.86K | ▼ -0.1% |
| 2006 | -9.08x | CA$-843.13K | CA$92.83K | ▼ -51.2% |
| 2005 | -6.01x | CA$-808.87K | CA$134.62K | ▼ -19.0% |
| 2004 | -5.05x | CA$-503.50K | CA$99.72K | ▲ +28.9% |
| 2003 | -7.10x | CA$-404.87K | CA$57.02K | — |